Lifecore Biomedical, Inc. (LFCR)
(Delayed Data from NSDQ)
$7.41 USD
+0.42 (6.01%)
Updated Aug 4, 2025 03:59 PM ET
After-Market: $7.43 +0.02 (0.27%) 7:58 PM ET
3-Hold of 5 3
C Value D Growth F Momentum D VGM
Fundamental Charts
About Market Cap
As of the previous market close, Lifecore Biomedical, Inc. has a market cap of $258.81M, which represents its share price of $6.99 multiplied by its outstanding shares number of 37.03M. As a small-cap company, LFCR's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
LFCR 7.41 +0.42(6.01%)
Will LFCR be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for LFCR based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for LFCR
Lifecore Biomedical (LFCR) Reports Q3 Loss, Misses Revenue Estimates
Dare Bioscience, Inc. (DARE) Reports Q4 Loss, Misses Revenue Estimates
LFCR: What are Zacks experts saying now?
Zacks Private Portfolio Services
Lifecore Biomedical (LFCR) Reports Q2 Loss, Tops Revenue Estimates
Other News for LFCR
Lifecore Biomedical to Report Fourth Quarter and Fiscal Year 2025 Financial Results on August ...
Laughing Water Capital Q2 2025 Letter
Lifecore Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | LFCR Stock News
Stock Picks From Seeking Alpha's June 2025 New Analysts
Lifecore Biomedical: Inflecting Financials Over Next 3 Years